Mark Plavsic

CIK: 0001868719

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)4 (66.7%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

AURA

Aura Biosciences, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

AURA
Aura Biosciences, Inc.
Mar 2, 2026
Award(A)
Direct
62.3K shares-
AURA
Aura Biosciences, Inc.
Feb 17, 2026
Sale(S)
Direct
15.9K shares at avg. $5.05$80K
AURA
Aura Biosciences, Inc.
Oct 16, 2025
Sale(S)
Direct
12.2K shares at avg. $6.35$77K
AURA
Aura Biosciences, Inc.
Feb 18, 2025
Sale(S)
Direct
2.2K shares at avg. $7.75$17K
AURA
Aura Biosciences, Inc.
Feb 3, 2025
Award(A)
Direct
90.5K shares-
AURA
Aura Biosciences, Inc.
Oct 16, 2024
Sale(S)
Direct
7.4K shares at avg. $9.85$73K

		Type	Shares	Price		Ownership
Mar 2, 2026	AURA Aura Biosciences, Inc.	Award(A)	62,339	-	$0	Direct
Feb 17, 2026	AURA Aura Biosciences, Inc.	Sale(S)	15,890	$5.05	$80,245	Direct
Oct 16, 2025	AURA Aura Biosciences, Inc.	Sale(S)	12,169	$6.35	$77,273	Direct
Feb 18, 2025	AURA Aura Biosciences, Inc.	Sale(S)	2,151	$7.75	$16,670	Direct
Feb 3, 2025	AURA Aura Biosciences, Inc.	Award(A)	90,475	-	-	Direct
Oct 16, 2024	AURA Aura Biosciences, Inc.	Sale(S)	7,383	$9.85	$72,723	Direct

1-6 of 6 transactions

About Plavsic Mark

Plavsic Mark (SEC CIK 0001868719) files insider reports with the SEC as Chief Technology Officer of Aura Biosciences, Inc. (AURA).

Signal8 holds 6 ownership filings by Plavsic Mark, all Form 4s, filed between Oct 16, 2024 and Mar 3, 2026. Those filings report 6 transactions, from Oct 16, 2024 to Mar 2, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Plavsic Mark's filings is in BOSTON, MA.

Recent filings by Plavsic Mark

Mar 2, 2026: Grant or award of AURA shares (Form 4, code A).
Feb 17, 2026: Open-market sale of AURA shares (Form 4, code S).
Oct 16, 2025: Open-market sale of AURA shares (Form 4, code S).
Feb 18, 2025: Open-market sale of AURA shares (Form 4, code S).
Feb 3, 2025: Grant or award of AURA shares (Form 4, code A).

Other insiders filing for Aura Biosciences, Inc. (AURA)

Person Julie, Chief People Officer
Kratz Erica, Chief Reg. & Quality Officer
Hopkins Janet Jill, Chief Medical Officer
Elazzouzi Amy, SVP, Finance & PAO
Abu-Absi Susan, Chief Operating Officer
Bender Jeremy, Director

How to read Form 4 transaction codes